Theravance Biopharma (TBPH) Shares Issued (2016 - 2025)
Historic Shares Issued for Theravance Biopharma (TBPH) over the last 13 years, with Q3 2025 value amounting to $258000.0.
- Theravance Biopharma's Shares Issued changed N/A to $258000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $411000.0, marking a year-over-year decrease of 1543.21%. This contributed to the annual value of $508000.0 for FY2024, which is 1779.94% down from last year.
- Latest data reveals that Theravance Biopharma reported Shares Issued of $258000.0 as of Q3 2025.
- Theravance Biopharma's Shares Issued's 5-year high stood at $108.2 million during Q2 2021, with a 5-year trough of -$1000.0 in Q3 2023.
- For the 5-year period, Theravance Biopharma's Shares Issued averaged around $12.1 million, with its median value being $133000.0 (2024).
- In the last 5 years, Theravance Biopharma's Shares Issued crashed by 20000.0% in 2023 and then plummeted by 2312.14% in 2024.
- Over the past 5 years, Theravance Biopharma's Shares Issued (Quarter) stood at $108.2 million in 2021, then plummeted by 99.71% to $314000.0 in 2022, then crashed by 44.9% to $173000.0 in 2023, then fell by 23.12% to $133000.0 in 2024, then soared by 93.98% to $258000.0 in 2025.
- Its last three reported values are $258000.0 in Q3 2025, $20000.0 for Q1 2025, and $133000.0 during Q4 2024.